Healthy volunteers test new drug VRG50635 for safety
Knowledge-focused
Completed
This early-phase study tested the safety and how the body absorbs a new drug called VRG50635. It involved 22 healthy adults aged 19 to 55. The goal was to check for side effects and measure drug levels in the blood, not to treat any disease.
Phase: PHASE1 • Sponsor: Verge Genomics • Aim: Knowledge-focused
Last updated May 17, 2026 02:03 UTC